Application of nanotechnologies for improved immune response against infectious diseases in the developing world
- 18 March 2010
- journal article
- review article
- Published by Elsevier BV in Advanced Drug Delivery Reviews
- Vol. 62 (4-5), 378-393
- https://doi.org/10.1016/j.addr.2009.11.011
Abstract
No abstract availableKeywords
This publication has 147 references indexed in Scilit:
- Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacyVaccine, 2009
- Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissuesAdvanced Drug Delivery Reviews, 2009
- Antigen Delivery with Poly(Propylacrylic Acid) Conjugation Enhances MHC-1 Presentation and T-Cell ActivationBioconjugate Chemistry, 2009
- HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysisThe Lancet, 2008
- Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infectionNature Immunology, 2008
- Controlled Surface Modification with Poly(ethylene)glycol Enhances Diffusion of PLGA Nanoparticles in Human Cervical MucusMolecular Pharmaceutics, 2008
- IL-15 as memory T-cell adjuvant for topical HIV-1 DermaVir vaccineVaccine, 2008
- Label-free Electronic Detection of the Antigen-Specific T-Cell Immune ResponseNano Letters, 2008
- A tough transitionNature, 2007
- Simultaneous targeting of HCV replication and viral binding with a single lentiviral vector containing multiple RNA interference expression cassettesMolecular Therapy, 2006